Market Tracker

12/11 5:15pm ET

Bristol-Myers Squibb Co (NYSE:BMY)

63.02
Delayed Data
As of 4:00pm ET
 +0.60 / +0.96%
Today’s Change
46.01
Today|||52-Week Range
66.10
+7.84%
Year-to-Date
Pfizer's (PFE) Talazoparib Emerges Superior in EMBRACA Study
11:08am / Zacks.com - Paid Partner Content
Celldex Begins Phase I Trial on Cancer Candidate CDX-1140
Dec 01 / Zacks.com - Paid Partner Content
Building a Circle of Competency
Dec 05 / GuruFocus News - Paid Partner Content
Cancer Space Update: Pfizer's Bavencio Fails in Phase III
Dec 01 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo's Lung Cancer Study Meets Early Success
Dec 01 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Chang...
Dec 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close62.42
Today’s open62.22
Day’s range62.09 - 63.41
Volume4,502,638
Average volume (3 months)5,468,095
Market cap$102.2B
Dividend yield2.54%
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+184.95%
Earnings growth (this year)+6.00%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+17.31%
P/E ratio24.7
Price/Sales5.05
Price/Book6.42

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.14+0.40%
NVONovo Nordisk+0.29+0.56%
CELGCelgene+1.91+1.80%
LLYEli Lilly and Co+0.22+0.25%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateJanuary 25, 2018
EPS forecast (this quarter)$0.67
Annual revenue (last year)$19.4B
Annual profit (last year)$4.5B
Net profit margin22.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Giovanni Caforio
CFO, EVP &
Head-Global Business Operations
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts